Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Warns About Invokana, Farxiga Risk of Acute Kidney Injury June 15, 2016 Irvin Jackson Add Your Comments Amid continuing reports of kidney problems linked to Invokana and Farxiga, federal drug regulators are warning about the risk of acute kidney injury associated with the new-generation diabetes drugs. In a drug safety communication issued yesterday, the FDA indicates that the makers of Invokana, Invokamet, Farxiga and Xigduo XR will be required to add stronger label warnings about the risk of kidney damage. The warning comes after more than 100 adverse event reports involving patients who suffered acute kidney injury, which may cause hospitalization or potentially lead to kidney failure and death. Invokana (canagliflozin) is a Johnson & Johnson drug that was just introduced in March 2013, as the first member of a new class of diabetes drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Farxiga (dapagliflozin) was introduced by Bristol-Myers Squibb and AstraZeneca in 2014, as the second drug in this class. Invokamet and Xigduo are combination treatments that contain the active ingredients of Invokana and Farxiga, respectively, together with the older diabetes drug metformin. Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA is warning patients to seek immediate medical attention if they experience symptoms of kidney injury from Invokana and Farxiga, which can include decreased urine and swelling of legs or feet. “A search of the FDA Adverse Event Reporting System (FAERS) database from March 29, 2013, to October 19, 2015, identified 101 cases of acute kidney injury with sufficient detail to confirm the diagnosis and demonstrate a temporal relationship with canagliflozin (73 patients) and dapagliflozin (28 patients),” the FDA indicates. “Hospitalization for evaluation and management of acute kidney injury was necessary in 96 of the 101 cases, and 22 cases involved admission to an intensive care unit.” The FDA notes that there were at least four deaths, two of which were heart-related, and 15 patients had to undergo dialysis due to kidney failure following Invokana or Farxiga use. Kidney Risks with Invokana and Farxiga Concerns about the risk of kidney problems from Invokana and Farxiga are not new, however, as the drugs work in a unique way by impacting the normal function of the kidneys. In May 2015, the Institute for Safe Medication Practices (ISMP) highlighted concerns about the risk of kidney failure associated with the drug after reviewing adverse event reports submitted to the FDA during the first year Invokana was on the market. The ISMP noted at that time that the potential safety signals involving kidney toxicity raise questions about whether the potential Invokana risks may actually outweigh the benefits provided by the diabetes drug. During the first year Invokana was on the market, ISMP highlighted 457 serious adverse event reports submitted to the FDA involving complications from Invokana. These adverse event reports typically only account for a small portion of the total problems associated with prescription medications on the market. Many of the reported Invokana problems involved kidney failure, kidney impairment or problems with kidney stones, urinary tract infections, dehydration, hypersensitivity and abnormal weight loss. Looking at reports to the FDA’s adverse event reporting system, the ISMP found that Invokana received more serious adverse event reports than 92% of the other drugs regularly monitored by the group. While the FDA only notes 101 reports in the warning issued this week, they may have used more stringent filtering requirements to determine which cases of acute kidney injury are likely to be linked to the medications. In addition, the FDA also noted that it is very likely that there are more cases that have gone unreported. The ISMP report also covered a much wider array of potentially kidney-related problems. The FDA notes that in about half of the cases it observed, acute kidney injury occurred within a month of starting Invokana or Farxiga treatment, and patients who discontinued using them showed signs of improvement. In addition to announcing that new Invokana and Farxga warnings will be required, the agency also urged doctors to be aware of factors that may increase the risk of kidney injury, such as hypovolemia, chronic renal insufficiency, congestive heart failure, and taking certain other medications, including diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and nonsteroidal anti-inflammatory drugs (NSAID) like Aleve and Motrin. The FDA also urged doctors to monitor patients’ kidney functions and immediately remove them from the drugs and begin treatment at the first signs of kidney injury. Invokana and Farxiga Lawsuits The warning comes as a growing number of Invokana lawsuits, Invokamet lawsuits, Farxiga lawsuits and Xigduo lawsuits are being pursued by individuals throughout the U.S., each involving allegations that the manufacturers introduced the new diabetes treatments without adequately researching the potential side effects or providing proper warnings for consumers and the medical community. Kidney damage is not the only safety problem linked to these two drugs since they hit the market. The FDA has also launched investigations into other potential side effects of Invokana, Farxiga and other SGLT2 inhibitors, including a risk that users may develop diabetic ketoacidosis, kidney infections, bone fractures and amputations of the limbs. Diabetic ketoacidosis (DKA) from Invokana and Farxiga involves a dangerous build up of acid in the blood, which may result in hospitalization or death. Late last year, the FDA required new Invokana warnings about ketoacidosis in December 2015, urging users to stop taking the drug and seek immediate medical attention if they experience symptoms like abdominal pain, fatigue, nausea, respiratory problems or vomiting. In September 2015, the FDA required new Invokana bone fracture warnings, indicating that the drug may also lead to decreased bone density. Earlier this month the FDA released a new Invokana safety warning, indicating that it may increase the risk of leg, foot, and toe amputations. However, the investigation into those potential side effects are ongoing. Although the medications have only been on the market for a few years, it is expected that hundreds, if not thousands, of product liability lawsuits may be filed over the new generation diabetes drugs in the coming months, as Invokana injury lawyers continue to review claims for individuals throughout the United States. Tags: Amputation, Diabetes, Diabetes Drugs, Dialysis, Farxiga, Invokana, Ketoacidosis, Kidney Damage, Kidney Injury Image Credit: | More Invokana Lawsuit Stories Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022 Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021 Study Finds No Link Between Bone Fractures And Invokana, Similar Diabetes Drugs September 22, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025) Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025) Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)
Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022
Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021
Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)
Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025)
Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)